Our Team

Members of our Senior Executive Team have years of experience in academia and industry and a shared ambition to make TrophiCells the leading clinical choice in cell therapeutics.

PROFESSOR ANTHONY HOLLANDER

Founder and CEO

Professor Anthony Hollander is the founder and CEO of TrophiCell and an internationally recognised leader in stem cell biology and regenerative medicine. TrophiCell is built on a proprietary technology platform originating from his research at the University of Liverpool, with a focus on translating novel stem cell science into clinically and commercially viable, scalable solutions. Anthony has a strong track record of innovation and company creation, having previously founded Azellon Ltd, which developed a cell-based therapy for knee cartilage repair. His career spans scientific discovery, clinical translation, and leadership of large, multi-partner programmes. As Pro-Vice-Chancellor for Research and Impact at the University of Liverpool, he has led university-wide research commercialisation activity, including creating over 20 new spinout companies over the past decade, and driving sustained growth in spinout formation, translation, and industrial engagement. He has held senior international roles, including President of the International Cartilage Repair Society, and has led major European collaborative programmes in tissue engineering, establishing extensive networks across academia, industry, and healthcare.

DR KAREN SULLIVAN

Director

Dr Karen Sullivan is a scientist and lawyer with over 20 years’ experience in technology commercialisation in the public and private sector. Whilst Director of Intellectual Asset Management and Commercialisation at ITI Life Sciences, a £150m public sector technology investment fund, she led a major investment in stem cell technology and later led on the development of a national stem cell strategy for Scotland for Scottish Enterprise. Karen has closed well over 100 technology transactions spanning all technology sectors and covering assignment, licences, options, Joint ventures and spin outs, and has served on national working groups on best practice in commercialisation of research. She brings many years of senior management experience and commercial acumen to the leadership of TrophiCell.